ATE321853T1 - Humanische pellino-polypeptide - Google Patents

Humanische pellino-polypeptide

Info

Publication number
ATE321853T1
ATE321853T1 AT01932711T AT01932711T ATE321853T1 AT E321853 T1 ATE321853 T1 AT E321853T1 AT 01932711 T AT01932711 T AT 01932711T AT 01932711 T AT01932711 T AT 01932711T AT E321853 T1 ATE321853 T1 AT E321853T1
Authority
AT
Austria
Prior art keywords
polypeptides
pellino
humanic
well
disclosed
Prior art date
Application number
AT01932711T
Other languages
English (en)
Inventor
Timothy A Bird
David J Cosman
Original Assignee
Immunex Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immunex Corp filed Critical Immunex Corp
Application granted granted Critical
Publication of ATE321853T1 publication Critical patent/ATE321853T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • C07H21/04—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids with deoxyribosyl as saccharide radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/20—Fusion polypeptide containing a tag with affinity for a non-protein ligand
    • C07K2319/23—Fusion polypeptide containing a tag with affinity for a non-protein ligand containing a GST-tag
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
    • C07K2319/43—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation containing a FLAG-tag

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT01932711T 2000-04-28 2001-04-27 Humanische pellino-polypeptide ATE321853T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US20019800P 2000-04-28 2000-04-28

Publications (1)

Publication Number Publication Date
ATE321853T1 true ATE321853T1 (de) 2006-04-15

Family

ID=22740715

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01932711T ATE321853T1 (de) 2000-04-28 2001-04-27 Humanische pellino-polypeptide

Country Status (10)

Country Link
US (3) US7169891B2 (de)
EP (1) EP1290160B1 (de)
AT (1) ATE321853T1 (de)
AU (1) AU2001259217A1 (de)
CY (1) CY1105555T1 (de)
DE (1) DE60118359T2 (de)
DK (1) DK1290160T3 (de)
ES (1) ES2261412T3 (de)
PT (1) PT1290160E (de)
WO (1) WO2001083739A2 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1290160B1 (de) * 2000-04-28 2006-03-29 Immunex Corporation Humanische pellino-polypeptide
US7250507B2 (en) * 2000-04-28 2007-07-31 Immunex Corporation Inhibitory Pellino nucleic acids
WO2002059611A2 (en) * 2001-01-02 2002-08-01 Tularik Inc. Diagnosis and treatment of cancer using mammalian pellino polypeptides and polynucleotides
ATE463505T1 (de) * 2001-04-20 2010-04-15 Inst Systems Biology Toll-ähnlichen-rezeptor-5-liganden und verwendungsverfahren
US8703146B2 (en) * 2001-04-20 2014-04-22 Institute For Systems Biology Toll-like receptor 5 ligands and methods of use
EP1451581A4 (de) * 2001-10-05 2006-01-11 Coley Pharm Gmbh Agonisten und antagonisten der signalisierung des toll-ähnlichen rezeptors 3
US7348418B2 (en) * 2002-02-08 2008-03-25 Memorial Sloan-Kettering Cancer Center Carcinoma-related genes and polypeptides and methods of use thereof
AU2003299206A1 (en) * 2002-09-12 2004-04-23 Cellzome Ag Protein complexes involved in neurological diseases
PT1786908E (pt) * 2004-08-18 2010-04-29 Bayer Cropscience Ag Plantas com um aumento da actividade da enzima de fosforilação do amido r3 nos plastídeos
WO2008121349A1 (en) * 2007-03-29 2008-10-09 University Of Delaware Tag and target delivery system
WO2009143987A1 (en) * 2008-05-26 2009-12-03 National University Of Ireland, Maynooth Viral encoded pellino protein and its uses
GB201223114D0 (en) * 2012-12-21 2013-02-06 Nat Univ Ireland Novel peptide
GB201309509D0 (en) * 2013-05-28 2013-07-10 Nat Univ Ireland Diagnostic marker for crohn's disease
WO2016040246A1 (en) * 2014-09-12 2016-03-17 The Procter & Gamble Company Method of making a skin care composition
KR102033215B1 (ko) * 2016-07-05 2019-10-16 성균관대학교산학협력단 건선 유발 동물 모델 및 이의 용도

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003502017A (ja) 1999-03-26 2003-01-21 ヒューマン ジノーム サイエンシーズ， インコーポレイテッド ４９個のヒト分泌タンパク質
EP1074617A3 (de) 1999-07-29 2004-04-21 Research Association for Biotechnology Primers für Synthese von ganzen-Länge cDNS und deren Anwendung
AU6181300A (en) 1999-07-29 2001-02-19 Helix Research Institute Liver cancer-associated genes
EP1290160B1 (de) * 2000-04-28 2006-03-29 Immunex Corporation Humanische pellino-polypeptide
US7250507B2 (en) * 2000-04-28 2007-07-31 Immunex Corporation Inhibitory Pellino nucleic acids
WO2002021138A2 (de) 2000-09-07 2002-03-14 Axaron Bioscience Ag Die m30-genfamilie und ihre verwendung
WO2002059611A2 (en) * 2001-01-02 2002-08-01 Tularik Inc. Diagnosis and treatment of cancer using mammalian pellino polypeptides and polynucleotides
US20040005615A1 (en) * 2002-05-24 2004-01-08 Jing Li Amplification and overexpression of oncogenes

Also Published As

Publication number Publication date
CY1105555T1 (el) 2010-07-28
US7169891B2 (en) 2007-01-30
PT1290160E (pt) 2006-07-31
ES2261412T3 (es) 2006-11-16
US20070264711A1 (en) 2007-11-15
EP1290160B1 (de) 2006-03-29
AU2001259217A1 (en) 2001-11-12
US20020168683A1 (en) 2002-11-14
EP1290160A2 (de) 2003-03-12
US6703487B2 (en) 2004-03-09
DE60118359D1 (de) 2006-05-18
WO2001083739A3 (en) 2002-12-19
DK1290160T3 (da) 2006-07-31
US20040034199A1 (en) 2004-02-19
DE60118359T2 (de) 2006-12-07
WO2001083739A2 (en) 2001-11-08

Similar Documents

Publication Publication Date Title
WO2001064835A8 (en) Novel nucleic acids and polypeptides
WO2020193688A3 (en) Immunogenic compositions and vaccines comprising african swine fever virus peptides and proteins and uses thereof
PT1290160E (pt) Polipeptideos pellino humanos
CY1113421T1 (el) Πυρηνικα οξεα και πολυπεπτιδια υποδοχεα
CY1118443T1 (el) Anti-tnf αντισωματα, συνθεσεις, μεθοδοι και χρησεις
DK1129190T3 (da) Human TSLP DNA og polypeptider
YU9404A (sh) Multimerna, usmerena kontrastna sredstva na bazi peptida
DE60144145D1 (de) Subtilisin-variante
MXPA04003333A (es) Remodelado y glicoconjugacion de peptidos.
IL175021A0 (en) Chromatin insulator, its preparation and use in protein expression
NO20032286D0 (no) Anvendelse av CLyA-hemolysin for utskillelse av proteiner
CY1117746T1 (el) Αντιγονα αιμοφιλου της γριπης και αντιστοιχα θραυσματα dna
WO2001064834A8 (en) Novel nucleic acids and polypeptides
NO20050091L (no) Fremgangsmater for fremstilling av fibrinogen
WO2002059315A3 (en) Human nucleic acids and polypeptides and methods of use thereof
DK1425404T3 (da) Vaccinia-MVA-E3L-mutanter og anvendelse deraf
DK1157100T3 (da) Oxaloacetathydrolase-defekte svampeværtsceller
WO2004053092A3 (en) Human pellino polypeptides
AU5554301A (en) Isolation and characterization of the csa operon (etec-cs4 pili) and methods of using same
EA200100395A1 (ru) Фармацевтическая композиция, содержащая фрагменты днк, кодирующей антигенный белок, обладающая противоопухолевым действием
WO2001088137A3 (en) Human myd88 adapter-like protein and functional fragments thereof
UA84831C2 (ru) Производные фактора коагуляции vii
DE60024977D1 (de) Klonierung und expression von haemophilus somnus transferrin-bindenden proteinen
ATE414905T1 (de) Diabetesmodell
WO2002046417A3 (en) Adipocyte complement related protein zacrp3x2

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1290160

Country of ref document: EP

REN Ceased due to non-payment of the annual fee